Truist Securities Maintains Laboratory Of America Holdings (LH) Buy Recommendation

Fintel reports that on July 28, 2023, Truist Securities maintained coverage of Laboratory Of America Holdings (NYSE:LH) with a Buy recommendation.

Analyst Price Forecast Suggests 26.81% Upside

As of July 6, 2023, the average one-year price target for Laboratory Of America Holdings is 273.98. The forecasts range from a low of 203.90 to a high of $309.75. The average price target represents an increase of 26.81% from its latest reported closing price of 216.05.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Laboratory Of America Holdings is 15,484MM, an increase of 4.05%. The projected annual non-GAAP EPS is 18.17.

What is the Fund Sentiment?

There are 1738 funds or institutions reporting positions in Laboratory Of America Holdings. This is a decrease of 65 owner(s) or 3.61% in the last quarter. Average portfolio weight of all funds dedicated to LH is 0.35%, a decrease of 11.98%. Total shares owned by institutions decreased in the last three months by 2.39% to 87,637K shares. The put/call ratio of LH is 0.56, indicating a bullish outlook.

What are Other Shareholders Doing?

LH / Laboratory Corp. Of America Holdings Shares Held by Institutions

VTSMX – Vanguard Total Stock Market Index Fund Investor Shares holds 2,742K shares representing 3.09% ownership of the company. In it’s prior filing, the firm reported owning 2,692K shares, representing an increase of 1.83%. The firm decreased its portfolio allocation in LH by 8.36% over the last quarter.

Wellington Management Group Llp holds 2,701K shares representing 3.05% ownership of the company. In it’s prior filing, the firm reported owning 2,690K shares, representing an increase of 0.42%. The firm decreased its portfolio allocation in LH by 86.35% over the last quarter.

VIMSX – Vanguard Mid-Cap Index Fund Investor Shares holds 2,069K shares representing 2.34% ownership of the company. In it’s prior filing, the firm reported owning 2,063K shares, representing an increase of 0.28%. The firm decreased its portfolio allocation in LH by 5.42% over the last quarter.

VFINX – Vanguard 500 Index Fund Investor Shares holds 2,067K shares representing 2.33% ownership of the company. In it’s prior filing, the firm reported owning 2,048K shares, representing an increase of 0.93%. The firm decreased its portfolio allocation in LH by 8.80% over the last quarter.

BLACKROCK EQUITY DIVIDEND FUND – BLACKROCK EQUITY DIVIDEND FUND Investor A holds 1,958K shares representing 2.21% ownership of the company. In it’s prior filing, the firm reported owning 1,677K shares, representing an increase of 14.36%. The firm increased its portfolio allocation in LH by 7.48% over the last quarter.

Laboratory Of America Holdings Background Information
(This description is provided by the company.)

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020.

Additional reading:

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Summarize this content to 100 words

Fintel reports that on July 28, 2023, Truist Securities maintained coverage of Laboratory Of America Holdings (NYSE:LH) with a Buy recommendation. Analyst Price Forecast Suggests 26.81% Upside As of July 6, 2023, the average one-year price target for Laboratory Of America Holdings is 273.98. The forecasts range from a low of 203.90 to a high of $309.75. The average price target represents an increase of 26.81% from its latest reported closing price of 216.05.

See our leaderboard of companies with the largest price target upside. The projected annual revenue for Laboratory Of America Holdings is 15,484MM, an increase of 4.05%. The projected annual non-GAAP EPS is 18.17. What is the Fund Sentiment? There are 1738 funds or institutions reporting positions in Laboratory Of America Holdings. This is a decrease of 65 owner(s) or 3.61% in the last quarter. Average portfolio weight of all funds dedicated to LH is 0.35%, a decrease of 11.98%. Total shares owned by institutions decreased in the last three months by 2.39% to 87,637K shares. The put/call ratio of LH is 0.56, indicating a bullish outlook. What are Other Shareholders Doing? VTSMX – Vanguard Total Stock Market Index Fund Investor Shares holds 2,742K shares representing 3.09% ownership of the company. In it’s prior filing, the firm reported owning 2,692K shares, representing an increase of 1.83%. The firm decreased its portfolio allocation in LH by 8.36% over the last quarter. Wellington Management Group Llp holds 2,701K shares representing 3.05% ownership of the company. In it’s prior filing, the firm reported owning 2,690K shares, representing an increase of 0.42%. The firm decreased its portfolio allocation in LH by 86.35% over the last quarter.

VIMSX – Vanguard Mid-Cap Index Fund Investor Shares holds 2,069K shares representing 2.34% ownership of the company. In it’s prior filing, the firm reported owning 2,063K shares, representing an increase of 0.28%. The firm decreased its portfolio allocation in LH by 5.42% over the last quarter. VFINX – Vanguard 500 Index Fund Investor Shares holds 2,067K shares representing 2.33% ownership of the company. In it’s prior filing, the firm reported owning 2,048K shares, representing an increase of 0.93%. The firm decreased its portfolio allocation in LH by 8.80% over the last quarter. BLACKROCK EQUITY DIVIDEND FUND – BLACKROCK EQUITY DIVIDEND FUND Investor A holds 1,958K shares representing 2.21% ownership of the company. In it’s prior filing, the firm reported owning 1,677K shares, representing an increase of 14.36%. The firm increased its portfolio allocation in LH by 7.48% over the last quarter. Laboratory Of America Holdings Background Information(This description is provided by the company.) Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020.

Additional reading: This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

https://www.nasdaq.com/articles/truist-securities-maintains-laboratory-of-america-holdings-lh-buy-recommendation-0 Truist Securities Maintains Laboratory Of America Holdings (LH) Buy Recommendation

Exit mobile version